Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 16, 2006

Arbor Vita and NoNO Collaborate on Stroke Treatment

  • Arbor Vita and NoNO partnered to develop and commercialize drugs for the treatment of stroke. The R&D collaboration combines Arbor Vita’s PDZ-based drug discovery platform with NoNO’s expertise in the area of neurological disorders.

    “Under this collaboration, we are developing drugs targeting PDZ-protein interactions to mitigate brain damage from cerebral ischemia, which could also extend to the treatment of neurotrauma, pain, Alzheimer’s, and other diseases,” states Peter Lu, M.D., founder, president, and CEO of Arbor Vita.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »